Enes Erul, Oncology Fellow at Ankara University, shared a post on LinkedIn:
“Honored to speak at the OncoDaily Cervical Cancer Summit 2026 on the current state of cervical cancer in Türkiye.
Cervical cancer is one of the few cancers we can truly prevent—and eliminate. We have screening. We have modern treatment. And we have the HPV vaccine. Yet we are still losing women to a preventable disease.
Vaccine hesitancy, misinformation, and unequal access keep turning prevention into a maternal tragedy. As clinicians, we see the human cost: women diagnosed too late, families disrupted, and patients we lose—despite having interventions that could have prevented cancer in the first place.
The next step is not discovery—it’s delivery:
- vaccination programs with culturally sensitive messaging
- myth-busting and trust-building in communities
- equitable access with measurable coverage targets
Türkiye has a strong screening infrastructure, but a persistent HPV vaccination gap remains. A promising 2025 policy shift aims to provide free HPV vaccination for 13-year-olds by year-end—and implementation will be crucial (delivery channels, catch-up strategy, supply chain/cold chain, safety reporting, and equity monitoring).
If we act decisively, elimination is achievable.”
More posts featuring Enes Erul.
